Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 April, 2021 02:19 IST
IPCA Laboratories Q3 consolidated net profit rises 35.42% to Rs 2,675 mn
Source: IRIS | 04 Feb, 2021, 06.21PM
Rating: NAN / 5 stars.
Comments  |  Post Comment

IPCA Laboratories, a Mumbai-based drugmaker, on February 4, reported a 35.42% rise in its consolidated net profit to Rs 2,675 million for the quarter-ended December.

The company had posted a net profit of Rs 1,975.4 million for the corresponding period of the previous fiscal.

Consolidated revenue from operations of the company grew 16.24% to Rs 14,098.3 million for the quarter compared to Rs 12,128.6 million for the same period a year ago.

EBITDA gained 34.1% at Rs 3,669 million in December 2020 against Rs 2,737 million in December 2019.

Total expenses increased 10.53% to Rs 10,987.1 million for the quarter compared to Rs 9,940.4 million for the same period a year ago.

IPCA Laboratories EPS increased to Rs 21.09 in December 2020 compared to Rs 15.63 in December 2019.

 Shares of the company declined Rs 37.30, or 1.83%, to settle  at  Rs 2,000.65.  The total volume of shares traded  was 30,978 at  the BSE (Thursday).

 Post Comment
Name Email
Security Code type    into this box
Related Articles
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer